Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 12

Teneligliptin and “Thorough QTc study”: thorough enough?

Authors Ghosal S

Received 24 June 2019

Accepted for publication 24 June 2019

Published 15 July 2019 Volume 2019:12 Pages 1141—1142


Checked for plagiarism Yes

Editor who approved publication: Prof. Dr. Juei-Tang Cheng

Samit Ghosal

Department of Endocrinology, Nightingale Hospital, Kolkata, India

I read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E14 recommendations for the industry was not followed.2 The recommended design to conduct such a trial was not universally followed (Table1).

View the original paper by Erande and colleagues

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]